Related references
Note: Only part of the references are listed.Surgery for meningioma in the elderly and long-term survival: comparison with an age- and sex-matched general population and with younger patients
Benjamin Brokinkel et al.
JOURNAL OF NEUROSURGERY (2017)
Brain invasion in otherwise benign meningiomas does not predict tumor recurrence
Peter Baumgarten et al.
ACTA NEUROPATHOLOGICA (2016)
Review of controversies in management of non-benign meningioma
Iddo Paldor et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
Seizures with meningioma
Matthew J. Shepard et al.
JOURNAL OF NEUROSURGERY (2016)
Seizures and invasive meningiomas
Mikhail Chernov
JOURNAL OF NEUROSURGERY (2016)
Analysis of the surgical benefits of 5-ALA-induced fluorescence in intracranial meningiomas: experience in 204 meningiomas
Matthias Millesi et al.
JOURNAL OF NEUROSURGERY (2016)
The Simpson grading revisited: aggressive surgery and its place in modern meningioma management
Konstantinos Gousias et al.
JOURNAL OF NEUROSURGERY (2016)
Brain Invasion in Meningiomas: The Rising Importance of a Uniform Neuropathologic Assessment After the Release of the 2016 World Health Organization Classification of Central Nervous System Tumors
Benjamin Brokinkel et al.
WORLD NEUROSURGERY (2016)
Brain Invasion in Meningiomas: Incidence and Correlations with Clinical Variables and Prognosis
Dorothee Cacilia Spille et al.
WORLD NEUROSURGERY (2016)
Atypical meningioma: Randomized trials are required to resolve contradictory retrospective results regarding the role of adjuvant radiotherapy
Hannah Yoon et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2015)
The ROAM/EORTC-1308 trial: Radiation versus Observation following surgical resection of Atypical Meningioma: study protocol for a randomised controlled trial
Michael D. Jenkinson et al.
TRIALS (2015)
Atypical Meningiomas: Recurrence, Reoperation, and Radiotherapy
Daniel R. Klinger et al.
WORLD NEUROSURGERY (2015)
The Role of Adjuvant Radiotherapy After Gross Total Resection of Atypical Meningiomas
Shaakir Hasan et al.
WORLD NEUROSURGERY (2015)
Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma
Johannes A. P. van de Nes et al.
NEUROPATHOLOGY (2015)
Expression of c-MET in Invasive Meningioma
Sumi Yun et al.
JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE (2015)
Decreased expression of LASS2 is associated with worse prognosis in meningiomas
Rong-Hu Ke et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas
Ilker Coven et al.
JOURNAL OF NEUROSURGERY (2014)
Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review
Gurvinder Kaur et al.
NEURO-ONCOLOGY (2014)
Management of Atypical Cranial Meningiomas, Part 1: Predictors of Recurrence and the Role of Adjuvant Radiation After Gross Total Resection
Sam Q. Sun et al.
NEUROSURGERY (2014)
Management of Atypical Cranial Meningiomas, Part 2: Predictors of Progression and the Role of Adjuvant Radiation After Subtotal Resection
Sam Q. Sun et al.
NEUROSURGERY (2014)
The influence of age on the histological grading of meningiomas
Jae-Sung Park et al.
NEUROSURGICAL REVIEW (2014)
Proteins involved in regulating bone invasion in skull base meningiomas
Fateme Salehi et al.
ACTA NEUROCHIRURGICA (2013)
Malignant potential of skull base versus non-skull base meningiomas: clinical series of 1,663 cases
Jan Frederick Cornelius et al.
ACTA NEUROCHIRURGICA (2013)
Miniaturized Handheld Confocal Microscopy Identifies Focal Brain Invasion in a Mouse Model of Aggressive Meningioma
Matthieu Peyre et al.
BRAIN PATHOLOGY (2013)
The Integrin Inhibitor Cilengitide Affects Meningioma Cell Motility and Invasion
Annette Wilisch-Neumann et al.
CLINICAL CANCER RESEARCH (2013)
Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy
Jack Hou et al.
NEUROSURGICAL FOCUS (2013)
miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cells
N. Kliese et al.
ONCOGENE (2013)
1H-MRS of intracranial meningiomas: What it can add to known clinical and MRI predictors of the histopathological and biological characteristics of the tumor?
Mikhail F. Chernov et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2011)
uPA/PAI-1 expression and uPA promoter methylation in meningiomas
Julia Annabel Kandenwein et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Reduced Activity of CD13/Aminopeptidase N (APN) in Aggressive Meningiomas Is Associated with Increased Levels of SPARC
Christian Mawrin et al.
BRAIN PATHOLOGY (2010)
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
Roger Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Pathological classification and molecular genetics of meningiomas
Christian Mawrin et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Integrins as Target: First Phase III Trial Launches, but Questions Remain
Andrea Carter
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Mitotic Count, Brain Invasion, and Location Are Independent Predictors of Recurrence-Free Survival in Primary Atypical and Malignant Meningiomas: A Study of 86 Patients
Andrej Vranic et al.
NEUROSURGERY (2010)
18F-FDG PET in the assessment of tumor grade and prediction of tumor recurrence in intracranial meningioma
Jeong Won Lee et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Expression of Integrin-α3 mRNA in Meningiomas and Its Correlation with Proliferation and Invasion
Jian Chen et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2009)
Erythropoietin receptor is expressed in meningiomas and lower levels are associated with tumour recurrence
O. Kuester et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)
Pathodiagnostic parameters for meningioma grading
A. Moradi et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
A typical and anaplastic meningiomas: prognostic implications of clinicopathological features
S-Y Yang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
A phase I trial of sorafenib (BAY 43-9006) for patients with recurrent or progressive malignant glioma (NABTT 0401)
L. B. Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma
L. Burt Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The astrocytic response towards invasive meningiomas
L. Zeltner et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2007)
Patterns of SPARC expression and basement membrane intactness at the tumour-brain border of invasive meningiomas
J. Schittenhelm et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2006)
Expression of extracellular matrix-degrading proteins in classic, atypical, and anaplastic meningiomas
A. Josefine U. von Randow et al.
PATHOLOGY RESEARCH AND PRACTICE (2006)
Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas
C Mawrin et al.
CLINICAL CANCER RESEARCH (2005)
The basement membrane at the tumour-brain interface of brain-invasive grade I meningiomas
J Fritz et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2005)
Histopathology and MIB-1 labeling index predicted recurrence of meningiomas - A proposal of diagnostic criteria for patients with atypical meningioma
DMT Ho et al.
CANCER (2002)
Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: A clinicopathologic study of 53 cases
A Perry et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis
TE VanMeter et al.
JOURNAL OF NEURO-ONCOLOGY (2001)
Telomerase activity and expression of the telomerase catalytic subunit, hTERT, in meningioma progression
M Simon et al.
JOURNAL OF NEUROSURGERY (2000)
Share Paper
